Genomic Variation in the <i>MAP3K5</i> Gene is Associated with β-Thalassemia Disease Severity and Hydroxyurea Treatment Efficacy

201328 citationsJournal Articlegreen Open Access

Authors

Our data suggest that these MAP3K5 variants are indicative of β-thalassemia disease severity and response to HU treatment.

Good health and well-being

Published in: Pharmacogenomics

Volume 14, Issue 5, pp. 469-483

Field-Weighted Citation Impact: 1.57